BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

964 related articles for article (PubMed ID: 12202354)

  • 1. Exploring the propensities of helices in PrP(C) to form beta sheet using NMR structures and sequence alignments.
    Dima RI; Thirumalai D
    Biophys J; 2002 Sep; 83(3):1268-80. PubMed ID: 12202354
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preventing misfolding of the prion protein by trimethylamine N-oxide.
    Bennion BJ; DeMarco ML; Daggett V
    Biochemistry; 2004 Oct; 43(41):12955-63. PubMed ID: 15476389
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Generating Bona Fide Mammalian Prions with Internal Deletions.
    Munoz-Montesino C; Sizun C; Moudjou M; Herzog L; Reine F; Chapuis J; Ciric D; Igel-Egalon A; Laude H; Béringue V; Rezaei H; Dron M
    J Virol; 2016 Aug; 90(15):6963-6975. PubMed ID: 27226369
    [TBL] [Abstract][Full Text] [Related]  

  • 4. X-ray diffraction analysis of scrapie prion: intermediate and folded structures in a peptide containing two putative alpha-helices.
    Inouye H; Kirschner DA
    J Mol Biol; 1997 May; 268(2):375-89. PubMed ID: 9159477
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Two-rung model of a left-handed beta-helix for prions explains species barrier and strain variation in transmissible spongiform encephalopathies.
    Langedijk JP; Fuentes G; Boshuizen R; Bonvin AM
    J Mol Biol; 2006 Jul; 360(4):907-20. PubMed ID: 16782127
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Local structural plasticity of the prion protein. Analysis of NMR relaxation dynamics.
    Viles JH; Donne D; Kroon G; Prusiner SB; Cohen FE; Dyson HJ; Wright PE
    Biochemistry; 2001 Mar; 40(9):2743-53. PubMed ID: 11258885
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular dynamics studies on the NMR and X-ray structures of rabbit prion proteins.
    Zhang J; Zhang Y
    J Theor Biol; 2014 Feb; 342():70-82. PubMed ID: 24184221
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Toward the molecular basis of inherited prion diseases: NMR structure of the human prion protein with V210I mutation.
    Biljan I; Ilc G; Giachin G; Raspadori A; Zhukov I; Plavec J; Legname G
    J Mol Biol; 2011 Sep; 412(4):660-73. PubMed ID: 21839748
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Peptides and proteins in neurodegenerative disease: helix propensity of a polypeptide containing helix 1 of the mouse prion protein studied by NMR and CD spectroscopy.
    Liu A; Riek R; Zahn R; Hornemann S; Glockshuber R; Wüthrich K
    Biopolymers; 1999; 51(2):145-52. PubMed ID: 10397798
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NMR structure of the mouse prion protein domain PrP(121-231).
    Riek R; Hornemann S; Wider G; Billeter M; Glockshuber R; Wüthrich K
    Nature; 1996 Jul; 382(6587):180-2. PubMed ID: 8700211
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Helices 2 and 3 are the initiation sites in the PrP(C) → PrP(SC) transition.
    Chen J; Thirumalai D
    Biochemistry; 2013 Jan; 52(2):310-9. PubMed ID: 23256626
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Introduction of glutamines into the B2-H2 loop promotes prion protein conversion.
    Avbelj M; Hafner-Bratkovič I; Jerala R
    Biochem Biophys Res Commun; 2011 Oct; 413(4):521-6. PubMed ID: 21910969
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Self-assembly of recombinant prion protein of 106 residues.
    Baskakov IV; Aagaard C; Mehlhorn I; Wille H; Groth D; Baldwin MA; Prusiner SB; Cohen FE
    Biochemistry; 2000 Mar; 39(10):2792-804. PubMed ID: 10704232
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Polypeptide chain folding in the hydrophobic core of hamster scrapie prion: analysis by X-ray diffraction.
    Inouye H; Kirschner DA
    J Struct Biol; 1998; 122(1-2):247-55. PubMed ID: 9724626
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Copper induces increased beta-sheet content in the scrapie-susceptible ovine prion protein PrPVRQ compared with the resistant allelic variant PrPARR.
    Wong E; Thackray AM; Bujdoso R
    Biochem J; 2004 May; 380(Pt 1):273-82. PubMed ID: 14969585
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Residue-specific mobility changes in soluble oligomers of the prion protein define regions involved in aggregation.
    Glaves JP; Ladner-Keay CL; Bjorndahl TC; Wishart DS; Sykes BD
    Biochim Biophys Acta Proteins Proteom; 2018 Sep; 1866(9):982-988. PubMed ID: 29935976
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Conformational polymorphism of the amyloidogenic peptide homologous to residues 113-127 of the prion protein.
    Satheeshkumar KS; Jayakumar R
    Biophys J; 2003 Jul; 85(1):473-83. PubMed ID: 12829502
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The emerging principles of mammalian prion propagation and transmissibility barriers: Insight from studies in vitro.
    Surewicz WK; Jones EM; Apetri AC
    Acc Chem Res; 2006 Sep; 39(9):654-62. PubMed ID: 16981682
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Conformational transitions in peptides containing two putative alpha-helices of the prion protein.
    Zhang H; Kaneko K; Nguyen JT; Livshits TL; Baldwin MA; Cohen FE; James TL; Prusiner SB
    J Mol Biol; 1995 Jul; 250(4):514-26. PubMed ID: 7542350
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detailed biophysical characterization of the acid-induced PrP(c) to PrP(β) conversion process.
    Bjorndahl TC; Zhou GP; Liu X; Perez-Pineiro R; Semenchenko V; Saleem F; Acharya S; Bujold A; Sobsey CA; Wishart DS
    Biochemistry; 2011 Feb; 50(7):1162-73. PubMed ID: 21189021
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 49.